184 related articles for article (PubMed ID: 34895050)
1. Sinomenine ameliorates cardiac hypertrophy by activating Nrf2/ARE signaling pathway.
Yuan M; Zhao B; Jia H; Zhang C; Zuo X
Bioengineered; 2021 Dec; 12(2):12778-12788. PubMed ID: 34895050
[TBL] [Abstract][Full Text] [Related]
2. Paeoniflorin alleviates AngII-induced cardiac hypertrophy in H9c2 cells by regulating oxidative stress and Nrf2 signaling pathway.
Ren S; Wang Y; Zhang Y; Yan P; Xiao D; Zhao Y; Jia W; Ding L; Dong H; Wei C; Lin S; Lin Y
Biomed Pharmacother; 2023 Sep; 165():115253. PubMed ID: 37542855
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
4. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
[TBL] [Abstract][Full Text] [Related]
5. [Fucoxanthin regulates Nrf2/Keap1 signaling to alleviate myocardial hypertrophy in diabetic rats].
Zheng D; Chen L; Wei Q; Zhu Z; Liu Z; Jin L; Yang G; Xie X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):752-759. PubMed ID: 35673921
[TBL] [Abstract][Full Text] [Related]
6. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway.
Zhao M; Guo H; Chen J; Fujino M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Wang J; Huang H; Zheng S; Hei M; Li J; Huang S; Li J; Ma X; Chen Y; Zhao L; Zhuang J; Zhu P; Li XK
Am J Physiol Cell Physiol; 2015 Apr; 308(8):C665-72. PubMed ID: 25652453
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
[TBL] [Abstract][Full Text] [Related]
8. GRK2 participation in cardiac hypertrophy induced by isoproterenol through the regulation of Nrf2 signaling and the promotion of NLRP3 inflammasome and oxidative stress.
Liu J; Li X; Ding L; Li W; Niu X; Gao D
Int Immunopharmacol; 2023 Apr; 117():109957. PubMed ID: 37012864
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
10. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
11. Sinomenine Attenuates Traumatic Spinal Cord Injury by Suppressing Oxidative Stress and Inflammation via Nrf2 Pathway.
Zhang L; Zhang W; Zheng B; Tian N
Neurochem Res; 2019 Apr; 44(4):763-775. PubMed ID: 30603983
[TBL] [Abstract][Full Text] [Related]
12.
Cao YY; Li K; Li Y; Tian XT; Ba HX; Wang A; Li XH
Pharm Biol; 2020 Dec; 58(1):176-183. PubMed ID: 33826488
[TBL] [Abstract][Full Text] [Related]
13. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
14. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF
J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333
[TBL] [Abstract][Full Text] [Related]
15. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
Wang NN; Wang J; Tan HL; Wang YG; Gao Y; Ma ZC
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1642-1647. PubMed ID: 31090329
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the Keap1-Nrf2-ARE pathway in the antioxidant activity of sinomenine.
Guan T; Li N; Xu X; Xiong D; Wang B; Xiao L; Yang W; Chu G; Yusuf A; Zhang J; Yue W
Arch Biochem Biophys; 2024 Mar; 753():109928. PubMed ID: 38354876
[TBL] [Abstract][Full Text] [Related]
17. Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.
Yan L; Zhang JD; Wang B; Lv YJ; Jiang H; Liu GL; Qiao Y; Ren M; Guo XF
PLoS One; 2013; 8(9):e72548. PubMed ID: 24039778
[TBL] [Abstract][Full Text] [Related]
18. Taurine attenuates isoproterenol-induced H9c2 cardiomyocytes hypertrophy by improving antioxidative ability and inhibiting calpain-1-mediated apoptosis.
Li W; Yang J; Lyu Q; Wu G; Lin S; Yang Q; Hu J
Mol Cell Biochem; 2020 Jun; 469(1-2):119-132. PubMed ID: 32304004
[TBL] [Abstract][Full Text] [Related]
19. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Nrf2/ARE Signalling Pathway to Mitigate Isoproterenol-Induced Cardiac Hypertrophy: Plausible Role of Hesperetin in Redox Homeostasis.
Velusamy P; Mohan T; Ravi DB; Kishore Kumar SN; Srinivasan A; Chakrapani LN; Singh A; Varadharaj S; Kalaiselvi P
Oxid Med Cell Longev; 2020; 2020():9568278. PubMed ID: 32952852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
